Skip to main content
OpenTrials

Clinical trial condition

Triple Negative Breast Neoplasms

Explore clinical trials studying Triple Negative Breast Neoplasms. Study availability and eligibility vary by location and protocol.

819 public trials 296 recruiting studies
Refine in advanced search Browse all conditions

Triple Negative Breast Neoplasms trial results

Completed

LTX-315 in Patients With Transdermally Accessible Tumours as Monotherapy or Combination With Ipilimumab or Pembrolizumab

NCT01986426

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +23 more
Locations
  • Jules Bordet Institute Brussels, Belgium
  • Cliniques Universitaires St-Luc, Service d'oncologie médicale Brussels, Belgium
  • Institut Curie Paris, France
  • Institute Gustave Roussy Paris, France
View all 14 locations
View Trial Details
Completed

Cisplatin, Paclitaxel, and Everolimus in Treating Patients With Metastatic Breast Cancer

NCT01031446

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +5 more
Locations
  • Erlanger Cancer Center at Erlanger Hospital - Baroness Chattanooga, Tennessee, United States
  • West Tennessee Cancer Center at Jackson-Madison County General Hospital Jackson, Tennessee, United States
  • Baptist Regional Cancer Center at Baptist Riverside Knoxville, Tennessee, United States
  • Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States
View Trial Details
Completed

Eribulin Versus Vinorelbine in Subjects With Locally Recurrent or Metastatic Breast Cancer Previously Treated With Anthracyclines and Taxanes

NCT02225470

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +9 more
Locations
  • 04 Eisai Trial Site Bengbu, Anhui, China
  • 37 Eisai Trial Site Hefei, Anhui, China
  • 01 Eisai Trial Site Beijing, Beijing Municipality, China
  • 03 Eisai Trial Site Beijing, Beijing Municipality, China
View all 35 locations
View Trial Details
Completed

Veliparib in Treating Patients With Malignant Solid Tumors That Do Not Respond to Previous Therapy

NCT00892736

Conditions
Adnexal Diseases, BRCA1 Mutation Carrier, BRCA2 Mutation Carrier, +48 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • City of Hope South Pasadena South Pasadena, California, United States
View Trial Details
Completed

Brostallicin and Cisplatin in Treating Patients With Metastatic Breast Cancer

NCT01091454

Conditions
Breast Diseases, Breast Neoplasms, Breast Neoplasms, Male, +6 more
Locations
  • Mayo Clinic Scottsdale Scottsdale, Arizona, United States
  • Aurora Presbyterian Hospital Aurora, Colorado, United States
  • Boulder Community Hospital Boulder, Colorado, United States
  • Penrose Cancer Center at Penrose Hospital Colorado Springs, Colorado, United States
View all 266 locations
View Trial Details

Related conditions